21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy

Background: The 21-gene recurrence score (RS) predicts risk of locoregional recurrence (LRR) in node-negative, estrogen receptor (ER)–positive breast cancer. We evaluated the association between RS and LRR in node-positive, ER-positive patients treated with adjuvant chemotherapy plus tamoxifen in Na...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Natl Cancer Inst
Asıl Yazarlar: Mamounas, Eleftherios P., Liu, Qing, Paik, Soonmyung, Baehner, Frederick L., Tang, Gong, Jeong, Jong-Hyeon, Kim, S. Rim, Butler, Steven M., Jamshidian, Farid, Cherbavaz, Diana B., Sing, Amy P., Shak, Steven, Julian, Thomas B., Lembersky, Barry C., Wickerham, D. Lawrence, Costantino, Joseph P., Wolmark, Norman
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721938/
https://ncbi.nlm.nih.gov/pubmed/28122895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw259
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller